Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Vasoactive intestinal peptide (VIP) is an anti-inflammatory immunomodulatory neuropeptide with therapeutic potential demonstrated for collagen-induced arthritis. The aim of this study was to characterise its potential anti-arthritic effect on human monocytes, macrophages, T cells, and rheumatoid art...
Huvudupphovsmän: | Foey, A, Field, S, Ahmed, S, Jain, A, Feldmann, M, Brennan, F, Williams, R |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
BioMed Central
2003
|
Liknande verk
-
The role of TNF alpha and IL-1 in rheumatoid arthritis.
av: Feldmann, M, et al.
Publicerad: (2001) -
Targeting TNF alpha for the therapy of rheumatoid arthritis.
av: Maini, R, et al.
Publicerad: (1994) -
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
av: Maini, R, et al.
Publicerad: (1993) -
TNF alpha is an effective therapeutic target for rheumatoid arthritis.
av: Feldmann, M, et al.
Publicerad: (1995) -
TNF alpha--a pivotal role in rheumatoid arthritis?
av: Brennan, F, et al.
Publicerad: (1992)